Bill Text: HI HB2572 | 2018 | Regular Session | Amended
Bill Title: Relating To The Medical Use Of Cannabis.
Spectrum: Partisan Bill (Democrat 5-0)
Status: (Introduced - Dead) 2018-02-15 - Passed Second Reading as amended in HD 1 and referred to the committee(s) on JUD with none voting aye with reservations; none voting no (0) and Representative(s) DeCoite, Ing, McDermott, Nakamura, Souki, Todd excused (6). [HB2572 Detail]
Download: Hawaii-2018-HB2572-Amended.html
|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
2572 |
|
TWENTY-NINTH LEGISLATURE, 2018 |
H.D. 1 |
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO THE MEDICAL USE OF CANNABIS.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. The legislature finds that the authority to accept the medical use of controlled substances rests with the states, which is why the State of Hawaii was able to accept the medical use of cannabis in 2000 and create a state regulated medical use of cannabis program.
However, some issues related to the medical use of cannabis remain unresolved, such as the implications of state and federal scheduling of cannabis as a schedule I controlled substance and the interaction of conflicting state and federal law regarding cannabis and its derivative products. These unresolved issues affect the State's ability to regulate certain aspects of the medical use of cannabis in context of uncertain federal enforcement policies.
The purpose of this Act is to convene the medical cannabis study group to examine the complexities surrounding the topic of the legality of medical cannabis.
SECTION 2. (a) There is established the medical cannabis study group to examine the complexities surrounding the topic of the legality of medical cannabis, including:
(1) The United States Attorney General's January 4, 2018 Memorandum For All United States Attorneys titled "Marijuana Enforcement";
(2) Article VI, clause 2 of the United States Constitution;
(3) The United States Constitution Amendment II;
(4) The United States Constitution Amendment X; and
(5) Additional resources pertaining to states' rights.
(b) The study group shall consist of the following members:
(1) Two members of the house of representatives, one of whom shall be selected by the speaker of the house of representatives and one of whom shall be selected by the minority leader of the house of representatives;
(2) Two members of the senate who are selected by the president of the senate;
(3) A medical doctor with expertise in medical cannabis and both state and federal rights and authority as it relates to the prescription of drugs to be selected jointly by the speaker of the house of representatives and the president of the senate;
(4) The attorney general; and
(5) A representative from the Hawaii Rifle Association.
(c) The members of the medical cannabis study group shall select a chair from among the members of the study group.
(d) The study group may request assistance and feedback from subject matter experts, as needed, to enable the study group to carry out its work.
(e) The study group shall submit a report of its
findings and recommendations, including any proposed legislation, to the
legislature no later than twenty days prior to the convening of the regular session
of 2019.
SECTION 3. This Act shall take effect on July 1, 3000.
Report Title:
Medical Use of Cannabis; Medical Cannabis Study Group
Description:
Establishes the Medical Cannabis Study Group to examine the complexities surrounding the topic of the legality of medical cannabis. (HB2572 HD1)
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.
